Protocol to evaluate sequential electronic health record-based strategies to increase genetic testing for breast and ovarian cancer risk across diverse patient populations in gynecology practices

BACKGROUND: Germline genetic testing is recommended by the National Comprehensive Cancer Network (NCCN) for individuals including, but not limited to, those with a personal history of ovarian cancer, young-onset (< 50 years) breast cancer, and a family history of ovarian cancer or male breast can...

Descripción completa

Detalles Bibliográficos
Autores principales: Symecko, Heather, Schnoll, Robert, Beidas, Rinad S., Bekelman, Justin E., Blumenthal, Daniel, Bauer, Anna-Marika, Gabriel, Peter, Boisseau, Leland, Doucette, Abigail, Powers, Jacquelyn, Cappadocia, Jacqueline, McKenna, Danielle B., Richardville, Robert, Cuff, Lauren, Offer, Ryan, Clement, Elizabeth G., Buttenheim, Alison M., Asch, David A., Rendle, Katharine A., Shelton, Rachel C., Fayanju, Oluwadamilola M., Wileyto, E. Paul, Plag, Martina, Ware, Sue, Shulman, Lawrence N., Nathanson, Katherine L., Domchek, Susan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629034/
https://www.ncbi.nlm.nih.gov/pubmed/37932730
http://dx.doi.org/10.1186/s13012-023-01308-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629034/
https://www.ncbi.nlm.nih.gov/pubmed/37932730
http://dx.doi.org/10.1186/s13012-023-01308-w

Ejemplares similares